Edition:
India

Wacker Chemie AG (WCHG.DE)

WCHG.DE on Xetra

85.58EUR
18 Apr 2019
Change (% chg)

€0.76 (+0.90%)
Prev Close
€84.82
Open
€84.82
Day's High
€85.74
Day's Low
€82.94
Volume
131,770
Avg. Vol
193,383
52-wk High
€157.05
52-wk Low
€70.08

Latest Key Developments (Source: Significant Developments)

Wacker Chemie Sees Two-Digit Sales Growth In Silicones Division In 2019
Thursday, 18 Apr 2019 

April 18 (Reuters) - Wacker Chemie AG ::FOR 2019, WACKER SILICONES DIVISION ANTICIPATES TWO-DIGIT SALES GROWTH IN SPECIALTIES AND PRICE STABILIZATION IN STANDARD PRODUCTS, WITH SUPPLY AND DEMAND BECOMING MORE BALANCED.FOR 2019, WACKER POLYMERS DIVISION EXPECTS ADDITIONAL GROWTH OPPORTUNITIES.  Full Article

Wacker Chemie: "2019 Is Not Going To Be An Easy Year"
Tuesday, 19 Mar 2019 

March 19 (Reuters) - Wacker Chemie AG ::FY EBIT 389.6 MILLION EUR VERSUS 423.7 MILLION EUR YEAR AGO.FY SALES ROSE 1 PERCENT TO 4.98 BILLION EUR.EBITDA DECLINES 8 PERCENT TO EUR930 MILLION DUE TO AS-YET PENDING INSURANCE COMPENSATION FOR LOSS EVENT AT SITE IN TENNESSEE.INCOME FROM CONTINUING OPERATIONS GROWS BY 4 PERCENT TO EUR260 MILLION.DIVIDEND PROPOSAL OF EUR2.50 PER SHARE EQUIVALENT TO A PAYOUT OF EUR124 MILLION.FOR 2019, WACKER EXPECTS SALES TO CLIMB BY A MID-SINGLE-DIGIT PERCENTAGE, WITH EBITDA 10 TO 20 PERCENT LOWER THAN A YEAR EARLIER.AIMS TO LIFT ITS SALES BY A MID-SINGLE-DIGIT PERCENTAGE.GROUP'S EBITDA IS LIKELY TO DECLINE 10 TO 20 PERCENT COMPARED WITH 2018.THIS IS DUE TO LOWER AVERAGE PRICES FOR POLYSILICON, DECREASING PRICES FOR STANDARD PRODUCTS, AND RISING ENERGY COSTS.NET INCOME IS PROJECTED TO BE SIGNIFICANTLY LOWER THAN A YEAR AGO.CHEMICAL DIVISIONS' TOTAL SALES FOR FIRST TWO MONTHS CLIMBED SOMEWHAT VERSUS SAME PERIOD LAST YEAR, FUELED BY VOLUME GROWTH.FOR Q1 2019, WACKER EXPECTS TOTAL GROUP SALES TO BE AT LAST YEAR'S LEVEL (Q1 2018: EUR1.22 BILLION).GROUP EBITDA IN Q1 2019 IS LIKELY TO CONTRACT MARKEDLY, AS LOWER AVERAGE PRICES FOR COMPANY'S PRODUCTS AND SIGNIFICANTLY HIGHER ENERGY PRICES ARE WEIGHING ON EARNINGS.CEO - FROM TODAY'S PERSPECTIVE, 2019 IS NOT GOING TO BE AN EASY YEAR.IN 2018, WACKER CHEMIE AG POSTED A RETAINED PROFIT OF EUR1,482.3 MILLION UNDER GERMAN COMMERCIAL CODE ACCOUNTING RULES.  Full Article

Wacker Chemie FY Income Up 4 Pct To EUR 260 Million
Friday, 18 Jan 2019 

Jan 18 (Reuters) - Wacker Chemie AG ::FY EBIT FELL 8 PERCENT TO 390 MILLION EUR.FY EBITDA FELL 8 PERCENT TO 930 MILLION EUR.FY SALES ROSE 1 PERCENT TO 4.98 BILLION EUR.EBIT FOR 2018 COMES IN AT EUR390 MILLION.FY INCOME FROM CONTINUING OPERATIONS REACHES EUR260 MILLION, UP 4 PERCENT VERSUS A YEAR EARLIER.  Full Article

Wacker Chemie: EBITDA For 2018 Expected To Be Below Guidance
Friday, 18 Jan 2019 

Jan 18 (Reuters) - Wacker Chemie AG ::DGAP-ADHOC: WACKER CHEMIE AG: EBITDA FOR 2018 EXPECTED TO BE BELOW GUIDANCE DUE TO STILL OUTSTANDING INSURANCE COMPENSATION.ANTICIPATES EBITDA OF ABOUT EUR930 MILLION FOR 2018.REASON FOR EBITDA DECREASE IS THAT 2018 EARNINGS GUIDANCE INCLUDED INSURANCE COMPENSATION THAT IS STILL OUTSTANDING FOR INCIDENT AT CHARLESTON, TENNESSEE.NET INCOME FROM CONTINUING OPERATIONS IS NOW EXPECTED TO BE SLIGHTLY HIGHER THAN A YEAR EARLIER.NET FINANCIAL DEBT IS LIKELY TO BE SOMEWHAT ABOVE EUR600 MILLION AT YEAR-END 2018.  Full Article

Wacker Chemie Expands Production Capacities For Silicone Rubber Worldwide
Tuesday, 18 Dec 2018 

Dec 18 (Reuters) - Wacker Chemie AG ::STRENGTHENS PORTFOLIO OF SPECIALTIES BY EXPANDING PRODUCTION CAPACITIES FOR SILICONE RUBBER WORLDWIDE.PLANS TO GRADUALLY RAISE ITS CAPACITIES BY A TOTAL OF 40,000 METRIC TONS PER YEAR BY 2021.  Full Article

Wacker Chemie Renames Newly Acquired Pharmaceutical Protein Production Facility In Netherlands
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Wacker Chemie AG ::NEWLY ACQUIRED PHARMACEUTICAL PROTEIN PRODUCTION SYNCO BIO PARTNERS B.V. IN THE NETHERLANDS IS NOW WACKER BIOTECH B.V..  Full Article

Wacker Chemie To Raise Prices For Silicone Rubber In Europe, Middle East And South America
Friday, 26 Oct 2018 

Oct 26 (Reuters) - Wacker Chemie AG ::TO RAISE PRICES FOR SILICONE RUBBER IN EUROPE, MIDDLE EAST AND IN SOUTH AMERICA AS OF NOVEMBER 1.TO RAISE PRICES FOR SILICONE RUBBER IN EUROPE, THE MIDDLE EAST AND IN SOUTH AMERICA.DEPENDING ON PRODUCT GROUP, REGION AND BUSINESS FIELD, THE PRICE INCREASE WILL RANGE UP TO 40 PERCENT.  Full Article

Wacker Chemie Affirms Guidance After 19 Pct Drop In Q3 EBITDA
Thursday, 25 Oct 2018 

Oct 25 (Reuters) - Wacker Chemie AG ::DGAP-NEWS: WACKER CHEMIE AG: AFTER FIRST NINE MONTHS, WACKER CONFIRMS FORECAST OF HIGHER SALES AND EBITDA FOR FULL-YEAR 2018.AS A RESULT, GROUP SALES FOR Q3 2018 COME IN AT EUR1.24 BILLION, DOWN 5 PERCENT YEAR OVER YEAR AND 7 PERCENT QUARTER OVER QUARTER.AT EUR242 MILLION, EBITDA DECREASES 19 PERCENT VERSUS LAST YEAR AND 7 PERCENT VERSUS A QUARTER AGO.NET INCOME FOR Q3 AMOUNTS TO EUR69 MILLION.NET INCOME FOR QUARTER AMOUNTED TO EUR68.9 MILLION.PROSPECTS REMAIN POSITIVE FOR THIS YEAR AND BEYOND.WACKER POLYSILICON USED MARKET SITUATION FOR INVENTORY REBUILDING, WHICH WILL ALLOW IT TO SUPPLY CUSTOMERS PROMPTLY ONCE DEMAND AND PRICES HAVE PICKED UP.WACKER SILICONES ANTICIPATES LIFTING ITS FULL-YEAR EBITDA SOMEWHAT HIGHER THAN PROJECTED.SEES WACKER POLYSILICON LIKELY POSTING YEAR-OVER-YEAR DECLINE OF AROUND 25 PERCENT IN FULL-YEAR SALES AND EBITDA.  Full Article

Wacker Chemie Wins FDA OK To Make Drug Substance In Chiesi's Retavase
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - Wacker Chemie AG ::SAYS OBTAINS FDA APPROVAL TO MANUFACTURE THE DRUG SUBSTANCE IN RETAVASE, A THROMBOLYSIS MEDICATION BY CHIESI‍​.  Full Article

Wacker Chemie Supervisory Board Extends Contract Of CEO Rudolf Staudigl
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - WACKER CHEMIE AG ::DGAP-NEWS: WACKER CHEMIE AG: SUPERVISORY BOARD EXTENDS THE CONTRACTS OF CEO RUDOLF STAUDIGL AND EXECUTIVE BOARD MEMBER CHRISTIAN HARTEL.RUDOLF STAUDIGL RE-APPOINTED AS PRESIDENT & CEO UNTIL 2021.  Full Article